Fraction size in radiation treatment for breast conservation in early breast cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  James, Melissa L ^b   Lehman, Margot ^a   Hider, Phil N ^c   Jeffery, Mark ^b   Francis, Daniel P ^d   Hickey, Brigid E ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC;

AUSTRALIA; AXILLARY LYMPH NODE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EMBASE; HEALTH CARE COST; HUMAN; INFORMATION RETRIEVAL; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL LITERATURE; MEDLINE; PATIENT SAFETY; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RIB FRACTURE; RISK REDUCTION; SENTINEL LYMPH NODE BIOPSY; SKIN TOXICITY; SYSTEMATIC REVIEW; TISSUE PRESERVATION; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

EID: 55049120271     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003860.pub2     Document Type: Review

References (94)

1. Owen 2006{published data only} Anon. A RCT comparing 3 radiotherapy fractionation schedules after local surgical excision for early breast cancer. UKCCCR trials register 1997.
2. * Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al.Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long term results of a randomised trial. Lancet Oncology 2006;7(6):467-71.
3. Owen JR, Yarnold JR, Bliss JM, Regan J. Broad B, Davisdon J, et al.Randomised comparison of a 13 fraction schedule with a conventional 25 fraction schedule of radiotherapy after local excision of early breast cancer: preliminary analysis. Radiotherapy and Oncology 1994 Suppl 1;32:10.
4. Yarnold J. Phase III randomised trial of radiotherapy fractionation regimens after local excision of mastectomy in women with early stage breast cancer. PDQ 2001.
5. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al.Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiation and Oncology 2005;75(1):9-17.
6. Yarnold J, Owen R, Ashton A, Broad B, Regan J, Bliss J, et al.Fractionation sensitivity of change in breast appearance after radiotherapy for early breast cancer: results of a phase III randomised trial. Breast Cancer Research and Treatment 2001;69(3):230.
7. Yarnold JR, Bliss JM, Regan J, Broad B, Davison J, Harrington F, et al.Randomised comparison of a 13-fraction schedule with a conventional 25-fraction schedule of radiotherapy after local excision of early breast cancer: preliminary analysis. Radiotherapy and Oncology 1994 Suppl 1;32:101.
8. Yarnold JR, Owen R, Bliss J. Randomised comparison of a 13 fraction schedule with a conventional 25 fraction schedule of radiotherapy after local excision of early breast cancer: a preliminary analysis. Clinical Oncology 1992;4(5):336.
9. Yarnold JR, Owen R, Bliss JM, Regan J, Broad B, Davison J, et al.Randomised comparison of a 13 fraction schedule with a conventional 25 fraction schedule of radiotherapy after local excision of early breast cancer: a preliminary analysis. British Journal of Cancer 1994;70 Suppl XXII:10.
10. Whelan 2002{published data only} OCOG (Ontario Cooperative Oncology Group). A randomised trial of hypofractionated radiotherapy post-lumpectomy in node negative breast cancer (study protocol). Unknown.
11. * Whelan T, Mackenzie R, Julian J, Levine M, Shelley W, Grimard L, et al.Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. Journal of the National Cancer Institute 2002;94(15):1143-50.
12. Whelan TJ, Mackenzie RG, Levine M, Shelley W, Julian J, Grimard L, et al.A randomised trial comparing two fractionation schedules for breast irradiation post-lumpectomy in node-negative breast cancer. Proceedings of the Society of Clinical Oncology. 2000; Vol. 19, issue 2a.
13. Angelakis 1973{published data only} Angelakis P, Papavasiliou C, Elias C. Twice per week treatment versus five times per week. A radiotherapeutic clinical trial. The British Journal of Radiology 1973;46(545):350-3.
14. Anon 1981{unpublished data only} * Anonymous. Randomised trial of the use of local excision, axillary node dissection and radiotherapy in the treatment of early breast cancer. UKCCR trials site (no longer funded).
15. Anon 1982{unpublished data only} Anonymous. Breast conservation for patients with early carcinoma of the breast. UKCCCCR trials register Ref 6166.
16. Anon 1999{unpublished data only} Anonymous. Standardization of breast radiotherapy (START) trial. START Trial Management Group. Clinical Oncology 1999; Vol. 11, issue 3:145-7.
17. Ash 1995{published data only} Ash DV, Benson EA, Sainsbury JR, Round C, Head C. Seven Year follow up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy- a report of the Yorkshire Breast Cancer Group. Clinical Oncology 1995;7(2):93-6. [: PMID 7619770]
18. Asrari 1999{published data only} Asrari F, Gage I. Radiation therapy in the management of breast cancer. Current Opinion in Oncology 1999;11(6):463-7.
19. Baglan 2001{published data only} Baglan KL, Martinez AA, Frazier RC, Kini VR, Kestin LL, Chen PY, et al.The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. International Journal of Radiation Oncology, Biology, Physics 2001;50(4):1003-11.
20. Baillet 1990{published data only} Baillet F, Housset M, Maylin C, Boisserie G, Bettahar R, Delanian S, et al.The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. International Journal of Radiation Oncology, Biology, Physics 1990;19(5):1131-3.
21. Bartelink 1998{published data only} Bartelink H. Radiotherapy in the management of early breast cancer: a review. European Journal of Cancer and Clinical Oncology 1998;24 (1):77-82.
22. Bates 1975{published data only} Bates TD. A prospective clinical trial of post-operative radiotherapy delivered in three fractions per week versus two fractions per week in breast carcinoma. Clinical Radiology 1975;26(3):297-304.
23. Bates 1988{published data only} Bates TD. The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. The British Journal of Radiology 1988;61(727):625-30.
24. Bedwinik 1990{published data only} Bedwinck J. Radiation therapy in isolated locoregional recurrence of breast cancer: decisions regarding dose, field size, and elective radiation of uninvolved sites. International Journal of Radiation Oncology, Biology, Physics 1990;19(4):1093-5.
25. Brinkley 1984{published data only} Brinkley D, Haybrittle JL, Houghton J. The Cancer Research Campaign trial for early breast cancer: an analysis of the radiotherapy data. The British Journal of Radiology 1984;57(676):309-16.
26. Bruce 1971{published data only} * Bruce J. Operable cancer of the breast. A controlled clinical trial. Cancer 1971;28(6):1443-52.
27. Di Biase 2002{published data only} Di Biase SJ, Komarnicky LT, Heron DE, Schwartz GF, Mansfield CM. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. International Journal of Radiation Oncology, Biology, Physics 2002;53(3):680-6.
28. Dvivedi 1978{published data only} Dvivedi M, Pradhan DG. Immediate results of weekly fractionation in external radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1978;4(7-8):573-8.
29. EBCTG 2000{published data only} Early Breast Cancer Trials Group. Favourable and unfavourable effects on long term survival of radiotherapy for early breast cancer. An overview of the randomised trials. Lancet 2000;355(9217):1757-7.
30. Fentiman 1991{published data only} Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HM, Turner P, et al.Iridium implant without external radiotherapy for operable breast cancer: a pilot study. European Journal of Cancer 1991;27(4):447-50.
31. Formenti 2002{published data only} Formenti SC, Rosenstein B, Skinner KA, Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumour bed in selected postmenopausal breast cancer patients - pilot feasibility study. Radiology 2002;222(1): 171-8.
32. Goel 2002{published data only} Goel A, Kaushal V, Hooda HS, Das BP. Comparison of two radiation dose schedules in post mastectomy carcinoma of the breast. Indian Journal of Medical Sciences 2000;54(7):278- 83.
33. Gorodetsky 1999{published data only} Gorodetsky R, Lotan C, Piggot K, Pierce LJ, Polyansky I, Dische S, et al.Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1999;45(4):893-900.
34. Kovarik 1995{published data only} Kovarik J, Svoboda VHJ, Kovarik J, Svoboda VHJ. Early tolerance of different organs to fast fractionation in clinical practice. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1451-4.
35. Liljegren 1993{published data only} Liljegren G, Holmberg L, Westman G. The cosmetic outcome in early breast cancer treated with sector resection with or without radiotherapy. Uppsala-Orebro Breast Cancer Study Group. European Journal of Cancer 1993;29A(15):2083-9.
36. Mladenovic 2001{published data only} Mladenovic J, Borojevic N, Cikaric S, Radosevic-Jelic LJ. Hypofractionated radiotherapy in elderly women with breast cancer. Journal of BUON 2001;6(1):49-54.
37. Moody 1994{published data only} Moody AM, Mayles WP, Bliss JM, A'Hern RP, Owen JR, Regan J, et al.The influence of breast size on late radiation effects and association with radiotherapy dose in homogeneity. Radiotherapy Oncology: Journal of the European Society of Therapeutic Radiology and Oncology 1994;33(2):106-12.
38. Moonen 1994{published data only} Moonen L, Bartelink H. Fractionation in radiotherapy. Cancer Treatment Reviews 1994;20(4):365-78.
39. Nyman 1994{published data only} Nyman J, Turesson I. Basal cell density in human skin for various fractionation schedules in radiotherapy. Radiotherapy Oncology 1994;33(2):117-24.
40. Nyman 1995{published data only} Nyman J, Turesson I. Does the interval between fractions matter in the range of 48 h in radiotherapy? A study of acute and late human skin reactions. Radiotherapy and Oncology 1995;34(3):171-8.
41. Olivotto 1996{published data only} Olivotto IA, Weir LM, Kim-Sing, Bajdik CD, Trevisan CH, Doll CM, et al.Late cosmetic results of short fractionation for breast conservation. Radiotherapy and Oncology 1996;41(1):7-13. [: PMID 8961362]
42. Ortholan 2003{published data only} Ortholan C, Hannoun-Levi JM, Ferrero JM, Largillier R, Courdi A. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. International Journal of Radiation Oncology, Biology, Physics 2003;61 Suppl(154):172.
43. Poortmans 2001{published data only} Poortmans PMP, Venselaar JLM, Struikmans H, Hurkmans CW, Davis JB, Huyskens D, et al.The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage IIII breast cancer. International Journal of Radiation Oncology, Biology, Physics 2001;49(5):1399-408.
44. Ptaszynski 1999{published data only} Ptaszynski A-M, Van den Bogaert W, Horiot J-C, Poortmans P, Fourquet A, Struikmans H, et al.Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation. Acta Oncologica 1999;38 Suppl 13:19-27.
45. Rodger 1998{published data only} Rodger A. Fears over radiotherapy fractionation regimens in breast cancer. Proposed UK trials needs to define techniques as well as numbers of treatments. BMJ 1998;317(7152):155-6.
46. Romestaing 1997{published data only} Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al.Role of 10 Gy boost in the conservative treatment of early breast cancer. Results of a randomized clinical trial in Lyon, France. Journal of Clinical Oncology 1997;15(3):963-8.
47. Sanguineti 2001{published data only} Sanguineti G, Del Mastro L, Guenzi M, Ricci P, Cavallari M, Canavese G, et al.Impact of chemotherapy dose-intensity on radiation dose intensity after breast conserving therapy. Annals of Oncology 2001;12(3):373-8.
48. Shelley 2000{published data only} Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for post lumpectomy breast cancer patients. International Journal of Radiation Oncology, Biology, Physics 2000;47(5):1219-28.
49. Svoboda 1992{published data only} Svoboda VH, Krawczyk J, Krawczyk A. Seventeen years experience with accelerated radiotherapy for carcinoma of the breast. International Journal of Radiation Oncology, Biology, Physics 1992;24(1):65-71.
50. Turesson 1984{published data only} Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction - II: Comparison of the effects of daily and twice-a-week fractionation on human skin. 1984 International Journal of Radiation Oncology, Biology, Physics;10(5):599-606.
51. van Tienhoven 1991{published data only} van Tienhoven G, van Bree NA, Mijnheer BJ, Bartelink H. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group. Radiotherapy Oncology 1991;22(4):290-8.
52. Veronesi 2001{published data only} Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al.A preliminary report of intraoperative radiation therapy (IORT) in limited stage breast cancers that are conservatively treated. European Journal of Cancer 2001;37(17): 2178-83.
53. Vicini 1997{published data only} Vicini FA, Chen PY, Fraile M, Gustafson GS, Edmundson GK, Jaffray DA, et al.Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. International Journal of Radiation Oncology, Biology, Physics 1997;38(2):301-10.
54. Vicini 2001{published data only} Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al.Accelerated Treatment of Breast Cancer. Journal of Clinical Oncology 2001;19(7):1993-2001.
55. Vrieling 2000{published data only} Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, et al.The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC'boost vs. no boost' trial. Radiotherapy and Oncology 2000;55(3):219-32.
56. Wallgren 1978{published data only} Wallgren A, Arner O, Bergström J, Blomstedt B, Granberg P, Karnström L, Räf L, Silfverswärd C. Preoperative radiotherapy in operable breast cancer. Results in the Stockholm Breast Cancer Trial. Cancer 1978;42(3): 1120-5.
57. Wazer 2002{published data only} Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al.Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. International Journal of Radiation Oncology, Biology, Physics 2002;53(4):889-97.
58. Yamada 1999{published data only} Yamada Y, Ackerman I, Franssen E, Mackenzie RG, Thomas G. Does the dose fractionation schedule influence the local control of adjuvant radiotherapy for early stage breast cancer?. International Journal of Radiation Oncology, Biology, Physics 1999;44(1):99-104.
59. Yarnold 1991{published data only} Yarnold JR. Early stage breast cancer: teatment options and results. British Medical Bulletin 1991;47(2):372-87.
60. Wallace 1993{published data only} Wallace LM, Priestman SG, Dunn JA, Priestman TJ. The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clinical Oncology 1993;5(4):228-33.
61. Yarnold 1999{published data only (unpublished sought but not used)} Yarnold J. Standardisation of breast radiotherapy (START) trial. International Standard Randomised Controlled Trial Number Register (http://www.controlled-trials.com/ISRCTN59368779/) 1999. [: ISRCTN59368779]
62. Aaronson 1988 Aaronson NK, Bartelink H, van Dongen JA, van Dam FS. Evaluation of breast conserving therapy: clinical, methodological and psychological perspectives. European Journal of Surgical Oncology 1988;14(2):133-40.
63. AIHW 2006 Australian Institute of Health and Welfare & National Breast Cancer Centre. Breast Cancer in Australia: an overview. No. 34. cat no. CAN 29. Vol. Cancer Series, Canberra: AIHW, 2006.
64. Al-Ghazal 2000 Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. European Journal of Cancer 2000;36(15):1938-43. [: PMID 11000574]
65. Altman 1992 Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1992.
66. Ash 2000 Ash D. Waiting times for Cancer Treatment. Clinical Oncology 2000;12(3):140. [: PMID 10942327]
67. Chouillet 1994 Chouillet AM, Bell CMJ, Hiscox JG. Management of Breast Cancer in southeast England. BMJ 1994;308(6922):168-71.
68. Deeks 2003 Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In: Alderson P, Green S, Higgins JPT editor(s). Cochrane Reviewers' Handbook 4.2.2. Vol. The Cochrane Library 2004, Issue 1, Chichester, UK: John Wiley & Sons Ltd, 2003.
69. EBCTCG 1995 Early Breast Cancer Trialists Colloborative group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomised trials. New England Journal of Medicine 1995;333(22): 1444-1455.
70. EBCTCG 2002 Early Breast Cancer Trialists Collaborative Group. Radiotherapy for Early Breast Cancer. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003647]
71. Fisher 1989 Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al.Eight year results of a randomized trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. New England Journal Of Medicine 1989;320(13):822-28.
72. Fleming 1997 Fleming I, Cooper J, Henson D, Hutter R, Kennedy B, Murphy G, et al.AJCC Cancer Staging Manual. 5th Edition. Philadelphia: Lippincott-Raven, 1997.
73. Fowler 1989 Fowler J. The linear quadratic formula and progress in fractionated radiotherapy. The British Journal of Radiology 1989;62(740):679-94.
74. Greenland 1985 Greenland S, Robbins J. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985;41(1):55-68.
75. Hall 1994 Hall EJ. Radiobiology for the Radiologist. 4th Edition. Philadelphia: JB Lippincott, 1994:277. [: ISBN 0 397-51248-1]
76. Higgins 2006 Higgins JPT, Green S. Assessment of study quality. Section 6. In: Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Chichester, UK: John Wiley & Sons, Ltd, 2006.
77. Mackillop 1994 Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. International Journal of Radiation Oncology, Biology, Physics 1994;30(1):221-8.
78. Mantel 1959 Mantel M, Haenszel WH. Statistical aspects of the analysis of data for retrospective studies of disease. Journal of the National Cancer Institute 1959;22(4):719-48.
79. Nattinger 2001 Nattinger AB, Kneusal RT, Hoffman RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. Journal of the National Cancer Institute 2001;93(17): 1344-6.
80. NBCC 2001 National Breast Cancer Centre. Clinical Practice Guidelines for Management of Early Breast Cancer. Canberra: NH&MRC, 2001:55. [: Cat.No 0142926]
81. NIH 1991 NIH consensus conference. The treatment of early breast cancer. JAMA 1991;265(3):391-5.
82. ONS 1999 Office of National Statistics. Registrations of cancer diagnosed in 1993-96, England and Wales. Health Statistics Quarterly 1999;04:59-70.
83. Ries 2004 Ries LA, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, editors. SEER cancer statistics review, 1973-1999. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/cgi_bin/csr/1975_2004/ search.pl#results. Accessed 31/08/07.
84. Romond 2005 Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al.Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.New England Journal of Medicine 2005;353(16):1673-84.
85. Schroen 2005 Schroen AT, Brenin DA, Kelly MD, Knaus WA, Slingluff CL Jr. Impact of patient distant to radiation therapy on mastectomy use in early-stage breast cancer patients. Journal of Clinical Oncology 2005;23(28):7074-80.
86. Steel 1987 Steel GG, Deacon JM, Duschesne GM, Horwich A, Kelland LR, Peacock JH. The dose-rate effect in human tumour cells. Radiotherapy and Oncology 1987;9(4):299-310.
87. Steel 1997 Steel GG, editor. Basic Clinical Radiobiology. 2nd Edition. London: Arnold, 1997.
88. Stitt 1992 Stitt JA, Fowler JF, Thomadsen BR, Buchler DA, Paliwal BP, Kinsella TJ. High dose rate intracavitary brachytherapy for carcinoma of the cervix: The Madison System 1: Clinical and radiobiological considerations. International Journal Of Radiation Oncology, Biology, Physics 1992;24(2):335-48.
89. Thames 1987 Thames HD, Hendry JH. Fractionation in Radiotherapy. London: Taylor and Francis, 1987.
90. Veronesi 1990 Veronesi U, Banfi A, Salvadori P, Luini A, Saccozzi R, Zucali R, et al.Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomised trial. European Journal of Cancer 1990;26(6):668-70.
91. Walker 1988 Walker AM, Martin-Moreno JM, Artalejo FR. Odd man out: a graphical approach to meta-analysis. American Journal of Public Health 1988;78(8):961-6.
92. Whelan 1993 Whelan T, Marcellus D, Clark RM, Levine M. Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario. Canadian Medical Association Journal 1993;149(9):1273-7.
93. Williams 1985 Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumours: implications for clinical studies of altered fractionation. International Journal of Radiation Oncology, Biology, Physics 1985;11(1):87-96.
94. Winchester 1992 Winchester DP, Cox JD. Standards for breast-conservation treatment. CA: Cancer Journal for Clinicians 1992;42(3):134-62.